Phase 1 Trial of Hypofractionated Stereotactic Re-Irradiation in Combination with Nivolumab, Ipilimumab, and Bevacizumab for Recurrent High-Grade Gliomas.
Neuro-oncology advances(2025)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Neuro-oncology advances(2025)